Skip to main content
Veterinary Medicines

TIOBARBITAL 0,5 g USO VETERINARIO 50 mg/ml POLVO PARA SOLUCION INYECTABLE

Authorised
  • SODIUM CARBONATE
  • Thiopental sodium

Product identification

Medicine name:
TIOBARBITAL 0,5 g USO VETERINARIO 50 mg/ml POLVO PARA SOLUCION INYECTABLE
Active substance:
  • SODIUM CARBONATE
  • Thiopental sodium
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • SODIUM CARBONATE
    6.50
    percent weight/weight
    /
    1.00
    Vial
  • Thiopental sodium
    0.53
    gram(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Powder for solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01A
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • B Braun Vetcare S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • B BRAUN MEDICAL S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 1249 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/04/2024
How useful was this page?:
Average: 1 (5 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."